Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
17.45
-0.10 (-0.57%)
At close: Sep 18, 2026, 4:00 PM EDT
17.55
+0.10 (0.57%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Eloxx Pharmaceuticals Employees
Eloxx Pharmaceuticals had 10 employees as of December 31, 2025. The number of employees decreased by 8 or -44.44% compared to the previous year.
Employees
10
Change (1Y)
-8
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$1,065,100
Market Cap
70.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | -8 | -44.44% |
| Dec 31, 2022 | 18 | -10 | -35.71% |
| Dec 31, 2021 | 28 | 3 | 12.00% |
| Dec 31, 2020 | 25 | -4 | -13.79% |
| Dec 31, 2019 | 29 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Acrivon Therapeutics | 76 |
| Pliant Therapeutics | 49 |
| Gain Therapeutics | 21 |
| Cingulate | 14 |
| Rein Therapeutics | 10 |
| OKYO Pharma | 5 |
ELOX News
- 1 day ago - Leerink bullish on Eloxx Pharmaceuticals, initiates with an Outperform - TheFly
- 1 day ago - Eloxx Pharmaceuticals initiated with an Outperform at Leerink - TheFly
- 8 days ago - Eloxx Pharmaceuticals files to sell 600,000 shares of common stock for holders - TheFly
- 8 days ago - Eloxx Pharmaceuticals Registration statement: Registration filing - Filings
- 8 days ago - Eloxx Pharmaceuticals says first patients dosed in Phase 2b Exact Study - TheFly
- 8 days ago - Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome - PRNewsWire
- 4 weeks ago - Eloxx Pharmaceuticals initiated with a Buy at Lucid Capital - TheFly
- 5 weeks ago - Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - PRNewsWire